Yes, CYDY purchased Pro-140 (now leronlimab) from PGNX for $3.5M and some milestone payments and royalties I believe. Dr. Maddon was the CEO of PGNX and developed Pro-140. I believe he still serves as a consultant for CYDY on occasion and NP has mentioned he has been pleasantly surprised by the mono and other developments of the drug. Additionally, PGNX will receive up to 5% royalty of net sales for 10 years, so Dr. Maddon / PGNX have interests aligned with shareholders to get leronlimab approved.
(1)
(0)
CytoDyn Inc (CYDY) Stock Research Links
Please do your own due diligence. All my posts and comments are not to be considered investment advice.